Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Teamwork in care: could shared Self-Care lessons ease the toll of breast cancer treatment?

NCT ID NCT07742969

Symptom relief Sponsor: Ulviye Aydan NACAK Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a structured education program, given to both breast cancer patients and their primary caregivers together, can improve self-care behaviors and reduce anxiety for patients, while also easing caregiver anxiety and burden. The program involves four weekly sessions covering topics like managing chemotherapy side effects, nutrition, fatigue, and infection prevention. Participants are randomly assigned to either receive this dyadic education or standard care, with outcomes measured using validated questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured dyadic self-care education program for breast cancer patients and their primary caregivers
What this could lead to
If effective, this program could become a standard support tool to help breast cancer patients and their caregivers better manage chemotherapy side effects, reduce anxiety, and lighten the caregiver's load.
What could go wrong
This is a relatively small, early-stage trial, so results may not apply to all patients. The benefits of education programs can vary widely, and the study relies on self-reported measures, which may not capture the full picture.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 156 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients: * Female patients aged 18 years or older. * Diagnosed with stage II or III breast cancer. * Aware of their breast cancer diagnosis. * Receiving outpatient chemotherapy after mastectomy. * Having received at least one cycle of an EC (epirubicin-cyclophosphamide) or AC (doxorubicin-cyclophosphamide) chemotherapy regimen. * Able to read and write Turkish. * Having a primary caregiver who is willing to participate in the study. * Living with the primary caregiver. * Conscious, able to communicate effectively, and able to provide informed consent. * No diagnosed psychiatric disorder. Primary Caregivers: * Aged 18 years or older. * Able to read and write Turkish. * Living with the patient. * Being the patient's spouse, parent, child, friend, or another relative. * Assuming the main responsibility for the patient's care. * Willing and able to cooperate and provide informed consent. * No diagnosed psychiatric disorder. Exclusion Criteria: Patients: * Having experienced a major adverse life event within the previous 3 months, such as bereavement or divorce. * Admission to an intensive care unit during the study. * Progression of the disease to stage IV breast cancer. * Death or loss to follow-up. Primary Caregivers: * Having experienced a major adverse life event within the previous 3 months, such as bereavement or divorce. * Deterioration in health that prevents continued participation. * Transfer of the primary caregiving responsibility to another person.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder breast cancer breast neoplasm Caregiver Burden

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Caregiver Caregiver anxiety Caregiver burden Dyadic intervention Education Self-care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.